Updated Clinical Practice Guidelines for the Diagnosis and Management of Long COVID

키워드

참고문헌 (153)

1. Soriano JB, "A clinical case definition of post-COVID-19 condition by a Delphi consensus", Lancet Infect Dis, 22, pp.e102~e107 (2022)
2. National Institute for Health and Care Excellence (NICE), "COVID-19 rapid guideline: managing the long-term effects of COVID-19", NICE, ~ (2020)
3. Yelin D, "ESCMID rapid guidelines for assessment and management of long COVID", Clin Microbiol Infect, 28, pp.955~972 (2022)
4. "Long COVID"[URL]
5. Kim Y, "Preliminary guidelines for the clinical evaluation and management of long COVID", Infect Chemother, 54, pp.566~597 (2022)
6. Chen C, "Global prevalence of post-coronavirus disease 2019(COVID-19)condition or long COVID : a meta-analysis and systematic review", J Infect Dis, 226, pp.1593~1607 (2022)
7. Davis HE, "Long COVID : major findings, mechanisms and recommendations", Nat Rev Microbiol, 21, pp.133~146 (2023)
8. Antonelli M, "Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2", Lancet, 399, pp.2263~2264 (2022)
9. Chen H, "Prevalence and clinical features of long COVID from omicron infection in children and adults", J Infect, 86, pp.e97~e99 (2023)
10. Zeng N, "A systematic review and meta-analysis of long term physical and mental sequelae of COVID-19 pandemic : call for research priority and action", Mol Psychiatry, 28, pp.423~433 (2023)
11. Kim Y, "One year follow-up of COVID-19 related symptoms and patient quality of life : a prospective cohort study", Yonsei Med J, 63, pp.499~510 (2022)
12. Kim Y, "Post-acute COVID-19 syndrome in patients after 12 months from COVID-19 infection in Korea", BMC Infect Dis, 22, pp.93~ (2022)
13. Global Burden of Disease Long COVID Collaborators, "Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021", JAMA, 328, pp.1604~1615 (2022)
14. Tsampasian V, "Risk factors associated with post-COVID-19 condition : a systematic review and meta-analysis", JAMA Intern Med, 183, pp.566~580 (2023)
15. Kim Y, "Significance and associated factors of long-term sequelae in patients after acute COVID-19 infection in Korea", Infect Chemother, 53, pp.463~476 (2021)
16. Su S, "Epidemiology, clinical presentation, pathophysiology, and management of long COVID : an update", Mol Psychiatry, 28, pp.4056~4069 (2023)
17. Bowe B, "Acute and postacute sequelae associated with SARS-CoV-2 reinfection", Nat Med, 28, pp.2398~2405 (2022)
18. Ramos-Casals M, "Systemic and organ-specific immune-related manifestations of COVID-19", Nat Rev Rheumatol, 17, pp.315~332 (2021)
19. Thaweethai T, "Development of a definition of postacute sequelae of SARS-CoV-2 infection", JAMA, 329, pp.1934~1946 (2023)
20. Kim Y, "Long COVID prevalence and impact on quality of life 2 years after acute COVID-19", Sci Rep, 13, pp.11207~ (2023)
21. Fernández-de-Las-Peñas C, "Post-COVID-19 symptoms 2 years after SARS-CoV-2 infection among hospitalized vs nonhospitalized patients", JAMA Netw Open, 5, pp.e2242106~ (2022)
22. Liao X, "Long-term sequelae of different COVID-19 variants : The original strain versus the Omicron variant", Glob Health Med, 4, pp.322~326 (2022)
23. Douaud G, "SARS-CoV-2 is associated with changes in brain structure in UK Biobank", Nature, 604, pp.697~707 (2022)
24. "Clinical management of COVID-19: Living guideline,Jun 23 2022"[URL]
25. Zheng B, "Prevalence, risk factors and treatments for post-COVID-19 breathlessness : a systematic review and meta-analysis", Eur Respir Rev, 31, pp.220071~ (2022)
26. Faverio P, "One-year pulmonary impairment after severe COVID-19 : a prospective, multicenter follow-up study", Respir Res, 23, pp.65~ (2022)
27. Kersten J, "Symptom burden correlates to impairment of diffusion capacity and exercise intolerance in long COVID patients", Sci Rep, 12, pp.8801~ (2022)
28. Durstenfeld MS, "Use of cardiopulmonary exercise testing to evaluate long COVID-19 symptoms in adults : a systematic review and meta-analysis", JAMA Netw Open, 5, pp.e2236057~ (2022)
29. Satterfield BA, "Cardiac involvement in the long-term implications of COVID-19", Nat Rev Cardiol, 19, pp.332~341 (2022)
30. Writing Committee MembersGulati M, "2021 AHA", ACC, CHEST, pp.SAEM, SCCT[DOI]
31. Zhou LP, "Interpretation of the 2022 ACC expert consensus decision pathway on cardiovascular sequelae of COVID-19 in adults : myocarditis and other myocardial involvement, post-acute sequelae of SARS-CoV-2 infection, and return to play", Zhonghua Xin Xue Guan Bing Za Zhi, 51, pp.1~5 (2023)
32. Whiteson JH, "Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of cardiovascular complications in patients with post-acute sequelae of SARS-CoV-2 infection(PASC)", PM R, 14, pp.855~878 (2022)
33. Zuin M, "One-year risk of myocarditis after COVID-19 infection : a systematic review and meta-analysis", Can J Cardiol, 39, pp.839~844 (2023)
34. Song WJ, "Confronting COVID-19-associated cough and the post-COVID syndrome : role of viral neurotropism, neuroinflammation, and neuroimmune responses", Lancet Respir Med, 9, pp.533~544 (2021)
35. Song DJ, "KAAACI evidence-based clinical practice guidelines for chronic cough in adults and children in Korea", Allergy Asthma Immunol Res, 10, pp.591~613 (2018)
36. Morice AH, "ERS guidelines on the diagnosis and treatment of chronic cough in adults and children", Eur Respir J, 55, pp.1901136~ (2020)
37. Kang YR, "Clinical characteristics of post-COVID-19 persistent cough in the Omicron era", Allergy Asthma Immunol Res, 15, pp.395~405 (2023)
38. Rao S, "Fatigue symptoms associated with COVID-19 in convalescent or recovered COVID-19 patients; a systematic review and meta-analysis", Ann Behav Med, 56, pp.219~234 (2022)
39. Aaronson LS, "Defining and measuring fatigue", Image J Nurs Sch, 31, pp.45~50 (1999)
40. Hoshijima H, "Incidence of long-term post-acute sequelae of SARS-CoV-2 infection related to pain and other symptoms : a systematic review and meta-analysis", PLoS One, 18, pp.e0250909~ (2023)
41. Cares-Marambio K, "Prevalence of potential respiratory symptoms in survivors of hospital admission after coronavirus disease 2019(COVID-19) : a systematic review and meta-analysis", Chron Respir Dis, 18, pp.14799731211002240~ (2021)
42. Malik P, "Post-acute COVID-19 syndrome(PCS)and health-related quality of life(HRQoL)-a systematic review and meta-analysis", J Med Virol, 94, pp.253~262 (2022)
43. Fernández-de-Las-Peñas C, "Fatigue and dyspnoea as main persistent post-COVID-19 symptoms in previously hospitalized patients : related functional limitations and disability", Respiration, 101, pp.132~141 (2022)
44. Boari GEM, "Short-term consequences of SARS-CoV-2-related pneumonia : a follow up study", High Blood Press Cardiovasc Prev, 28, pp.373~381 (2021)
45. Horwitz LI, "Six-month outcomes in patients hospitalized with severe COVID-19", J Gen Intern Med, 36, pp.3772~3777 (2021)
46. Naik S, "Post COVID-19 sequelae : a prospective observational study from Northern India", Drug Discov Ther, 15, pp.254~260 (2021)
47. Frontera JA, "A prospective study of long-term outcomes among hospitalized COVID-19 patients with and without neurological complications", J Neurol Sci, 426, pp.117486~ (2021)
48. Gupta A, "Long-Term X-ray findings in patients with coronavirus disease-2019", Cureus, 13, pp.e15304~ (2021)
49. Kozak R, "Recognition of long-COVID-19 patients in a Canadian tertiary hospital setting : a retrospective analysis of their clinical and laboratory characteristics", Pathogens, 10, pp.1246~ (2021)
50. Liu T, "Twelve-month systemic consequences of coronavirus disease 2019(COVID-19)in patients discharged from hospital : a prospective cohort study in Wuhan, China", Clin Infect Dis, 74, pp.1953~1965 (2022)
51. Bai F, "Female gender is associated with long COVID syndrome : a prospective cohort study", Clin Microbiol Infect, 28, pp.611~ (2022)
52. Hellemons ME, "Persistent health problems beyond pulmonary recovery up to 6 months after hospitalization for COVID-19 : a longitudinal study of respiratory, physical, and psychological outcomes", Ann Am Thorac Soc, 19, pp.551~561 (2022)
53. Lombardo MDM, "Long-term coronavirus disease 2019 complications in inpatients and outpatients : a one-year follow-up cohort study", Open Forum Infect Dis, 8, pp.ofab384~ (2021)
54. Daugherty SE, "Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection : retrospective cohort study", BMJ, 373, pp.n1098~ (2021)
55. Yomogida K, "Post-acute sequelae of SARS-CoV-2 infection among adults aged ≥18 years-Long Beach, California, April 1-December 10, 2020", MMWR Morb Mortal Wkly Rep, 70, pp.1274~1277 (2021)
56. Karaarslan F, "Postdischarge rheumatic and musculoskeletal symptoms following hospitalization for COVID-19 : prospective follow-up by phone interviews", Rheumatol Int, 41, pp.1263~1271 (2021)
57. Hossain MA, "Prevalence of long COVID symptoms in Bangladesh : a prospective inception cohort study of COVID-19 survivors", BMJ Glob Health, 6, pp.e006838~ (2021)
58. Staudt A, "Associations of post-acute COVID syndrome with physiological and clinical measures 10 months after hospitalization in patients of the first wave", Eur J Intern Med, 95, pp.50~60 (2022)
59. Daynes E, "Early experiences of rehabilitation for individuals post-COVID to improve fatigue, breathlessness exercise capacity and cognition-a cohort study", Chron Respir Dis, 18, pp.14799731211015691~ (2021)
60. Gawron VJ, "Overview of self-reported measures of fatigue", Int J Aerosp Psychol, 26, pp.120~131 (2016)
61. chronic fatigue syndrome: redefining an illness, "Institute of Medicine. Beyond myalgic encephalomyelitis", pp.National Academies Press, Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis
62. Antoniou KM, "European respiratory society statement on long COVID follow-up", Eur Respir J, 60, pp.2102174~ (2022)
63. Melamed E, "Multidisciplinary collaborative consensus guidance statement on the assessment and treatment of neurologic sequelae in patients with post-acute sequelae of SARS-CoV-2 infection(PASC)", PM R, 15, pp.640~662 (2023)
64. Jennings G, "A systematic review of persistent symptoms and residual abnormal functioning following acute COVID-19 : ongoing symptomatic phase vs. post-COVID-19 syndrome", J Clin Med, 10, pp.5913~ (2021)
65. Michelen M, "Characterising long COVID : a living systematic review", BMJ Glob Health, 6, pp.e005427~ (2021)
66. Fernández-de-Las-Peñas C, "Time course prevalence of post-COVID pain symptoms of musculoskeletal origin in patients who had survived severe acute respiratory syndrome coronavirus 2 infection : a systematic review and meta-analysis", Pain, 163, pp.1220~1231 (2022)
67. Agergaard J, "Myopathic changes in patients with long-term fatigue after COVID-19", Clin Neurophysiol, 132, pp.1974~1981 (2021)
68. Martelletti P, "Long-COVID headache", SN Compr Clin Med, 3, pp.1704~1706 (2021)
69. Premraj L, "Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome : a meta-analysis", J Neurol Sci, 434, pp.120162~ (2022)
70. Bolay H, "COVID-19 is a real headache!", Headache, 60, pp.1415~1421 (2020)
71. Diaz-Mitoma F, "Increased frequency of Epstein-Barr virus excretion in patients with new daily persistent headaches", Lancet, 1, pp.411~415 (1987)
72. Rozen TD, "Daily persistent headache after a viral illness during a worldwide pandemic may not be a new occurrence : lessons from the 1890 Russian", Asiatic flu, 2020, pp.40, 1406~1409
73. Sisó-Almirall A, "Long Covid-19 : proposed primary care clinical guidelines for diagnosis and disease management", Int J Environ Res Public Health, 18, pp.4350~ (2021)
74. Fine JS, "Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of cognitive symptoms in patients with post-acute sequelae of SARS-CoV-2 infection(PASC)", PM R, 14, pp.96~111 (2022)
75. Jung YH, "Neurological and psychiatric manifestations of post-COVID-19 conditions", J Korean Med Sci, 38, pp.e83~ (2023)
76. Nurek M, "Recommendations for the recognition, diagnosis, and management of long COVID : a Delphi study", Br J Gen Pract, 71, pp.e815~e825 (2021)
77. Patel UK, "Long-term neurological sequelae among severe COVID-19 patients : a systematic review and meta-analysis", Cureus, 14, pp.e29694~ (2022)
78. Yuan N, "Post-acute COVID-19 symptom risk in hospitalized and non-hospitalized COVID-19 survivors : a systematic review and meta-analysis", Front Public Health, 11, pp.1112383~ (2023)
79. Whiteside DM, "Outcomes in post-acute sequelae of COVID-19(PASC)at 6 months post-infection Part 1 : cognitive functioning", Clin Neuropsychol, 36, pp.806~828 (2022)
80. Li L, "Association of a prior psychiatric diagnosis with mortality among hospitalized patients with coronavirus disease 2019(COVID-19)infection", JAMA Netw Open, 3, pp.e2023282~ (2020)
81. Hosey MM, "Survivorship after COVID-19 ICU stay", Nat Rev Dis Primers, 6, pp.60~ (2020)
82. Taquet M, "6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19 : a retrospective cohort study using electronic health records", Lancet Psychiatry, 8, pp.416~427 (2021)
83. Deng J, "The prevalence of depression, anxiety, and sleep disturbances in COVID-19 patients : a meta-analysis", Ann N Y Acad Sci, 1486, pp.90~111 (2021)
84. Salehinejad MA, "Circadian disturbances, sleep difficulties and the COVID-19 pandemic", Sleep Med, 91, pp.246~252 (2022)
85. Chinvararak C, "Prevalence of sleep disturbances in patients with long COVID assessed by standardised questionnaires and diagnostic criteria : a systematic review and meta-analysis", J Psychosom Res, 175, pp.111535~ (2023)
86. Bourne RS, "Sleep disruption in critically ill patients--pharmacological considerations", Anaesthesia, 59, pp.374~384 (2004)
87. Benítez ID, "Sleep and circadian health of critical COVID-19 survivors 3 months after hospital discharge", Crit Care Med, 50, pp.945~954 (2022)
88. Guedj E, "18F-FDG brain PET hypometabolism in patients with long COVID", Eur J Nucl Med Mol Imaging, 48, pp.2823~2833 (2021)
89. Miles A, "Current opinion of presentation of dysphagia and dysphonia in patients with coronavirus disease 2019", Curr Opin Otolaryngol Head Neck Surg, 30, pp.393~399 (2022)
90. Aoyagi Y, "Clinical manifestation, evaluation, and rehabilitative strategy of dysphagia associated with COVID-19", Am J Phys Med Rehabil, 100, pp.424~431 (2021)
91. Yang S, "Clinical practice guidelines for oropharyngeal dysphagia", Ann Rehabil Med, 47(Suppl 1), pp.S1~S26 (2023)
92. Malaty J, "Smell and taste disorders in primary care", Am Fam Physician, 88, pp.852~859 (2013)
93. Espetvedt A, "The assessment of qualitative olfactory dysfunction in COVID-19 patients : a systematic review of tools and their content validity", Front Psychol, 14, pp.1190994~ (2023)
94. Tan BKJ, "Prognosis and persistence of smell and taste dysfunction in patients with covid-19 : meta-analysis with parametric cure modelling of recovery curves", BMJ, 378, pp.e069503~ (2022)
95. Hartle M, "Dissecting the nature of post-exertional malaise", Fatigue, 9, pp.33~44 (2021)
96. Edward JA, "Characteristics and treatment of exercise intolerance in patients with long COVID", J Cardiopulm Rehabil Prev, 43, pp.400~406 (2023)
97. Jason LA, "The development of an instrument to assess post-exertional malaise in patients with myalgic encephalomyelitis and chronic fatigue syndrome", J Health Psychol, 26, pp.238~248 (2021)
98. Singh I, "Persistent exertional intolerance after COVID-19 : insights from invasive cardiopulmonary exercise testing", Chest, 161, pp.54~63 (2022)
99. Cotler J, "A brief questionnaire to assess post-exertional malaise", Diagnostics(Basel), 8, pp.66~ (2018)
100. Agarwal AK, "Postural orthostatic tachycardia syndrome", Postgrad Med J, 83, pp.478~480 (2007)
101. Carmona-Torre F, "Dysautonomia in COVID-19 patients : a narrative review on clinical course, diagnostic and therapeutic strategies", Front Neurol, 13, pp.886609~ (2022)
102. Eldokla AM, "Autonomic function testing in long-COVID syndrome patients with orthostatic intolerance", Auton Neurosci, 241, pp.102997~ (2022)
103. Goldstein DS, "The possible association between COVID-19 and postural tachycardia syndrome", Heart Rhythm, 18, pp.508~509 (2021)
104. Mayuga KA, "Sinus tachycardia : a multidisciplinary expert focused review", Circ Arrhythm Electrophysiol, 15, pp.e007960~ (2022)
105. Zulbaran-Rojas A, "Electrical stimulation to regain lower extremity muscle perfusion and endurance in patients with post-acute sequelae of SARS CoV-2 : a randomized controlled trial", Physiol Rep, 11, pp.e15636~ (2023)
106. Rutkowski S, "Inpatient post-COVID-19 rehabilitation program featuring virtual reality-Preliminary results of randomized controlled trial", Front Public Health, 11, pp.1121554~ (2023)
107. Palau P, "Effect of a home-based inspiratory muscle training programme on functional capacity in postdischarged patients with long COVID : the InsCOVID trial", BMJ Open Respir Res, 9, pp.e001439~ (2022)
108. Jimeno-Almazán A, "Effects of a concurrent training, respiratory muscle exercise, and self-management recommendations on recovery from post-COVID-19 conditions : the RECOVE trial", J Appl Physiol(1985), 134, pp.95~104 (2023)
109. Del Corral T, "Home-based respiratory muscle training on quality of life and exercise tolerance in long-term post-COVID-19 : randomized controlled trial", Ann Phys Rehabil Med, 66, pp.101709~ (2023)
110. Jimeno-Almazán A, "Rehabilitation for post-COVID-19 condition through a supervised exercise intervention : a randomized controlled trial", Scand J Med Sci Sports, 32, pp.1791~1801 (2022)
111. McNarry MA, "Inspiratory muscle training enhances recovery post-COVID-19 : a randomised controlled trial", Eur Respir J, 60, pp.2103101~ (2022)
112. Philip KEJ, "An online breathing and wellbeing programme(ENO Breathe)for people with persistent symptoms following COVID-19 : a parallel-group, single-blind, randomised controlled trial", Lancet Respir Med, 10, pp.851~862 (2022)
113. Catalán IP, "Corticosteroids for COVID-19 symptoms and quality of life at 1 year from admission", J Med Virol, 94, pp.205~210 (2022)
114. Kerget B, "Comparison of two antifibrotic treatments for lung fibrosis in post-COVID-19 syndrome : A randomized, prospective study", Med Clin(Barc), 160, pp.525~530 (2023)
115. Glynne P, "Long COVID following mild SARS-CoV-2 infection : characteristic T cell alterations and response to antihistamines", J Investig Med, 70, pp.61~67 (2022)
117. Smith ME, "Treatment of myalgic encephalomyelitis", chronic fatigue syndrome : a systematic review for a National Institutes of Health pathways to prevention workshop, 2015, pp.162, 841~850
118. Fowler-Davis S, "A mixed-methods systematic review of post-viral fatigue interventions : are there lessons for long Covid?", PLoS One, 16, pp.e0259533~ (2021)
119. Blitshteyn S, "Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of autonomic dysfunction in patients with post-acute sequelae of SARS-CoV-2 infection(PASC)", PM R, 14, pp.1270~1291 (2022)
120. Soin A, "Low-dose naltrexone use for patients with chronic regional pain syndrome : a systematic literature review", Pain Physician, 24, pp.E393~E406 (2021)
121. Membrilla JA, "Persistent headache after COVID-19 : Pathophysioloy, clinic and treatment", Neurology Perspectives, 1, pp.S31~S36 (2021)
122. MaassenVanDenBrink A, "Headache medication and the COVID-19 pandemic", J Headache Pain, 21, pp.38~ (2020)
123. Huang C, "6-month consequences of COVID-19 in patients discharged from hospital : a cohort study", Lancet, 397, pp.220~232 (2021)
124. "Clinical Practice Guideline of Pharmacologic Treatment for Migraine Prevention in Adults 2021"[URL]
125. Farahani RH, "Effect of fluvoxamine on preventing neuropsychiatric symptoms of post COVID syndrome in mild to moderate patients, a randomized placebo-controlled double-blind clinical trial", BMC Infect Dis, 23, pp.197~ (2023)
126. Mazza MG, "Rapid response to selective serotonin reuptake inhibitors in post-COVID depression", Eur Neuropsychopharmacol, 54, pp.1~6 (2022)
127. Nobile B, "The anti-inflammatory effect of the tricyclic antidepressant clomipramine and its high penetration in the brain might be useful to prevent the psychiatric consequences of SARS-CoV-2 infection", Front Pharmacol, 12, pp.615695~ (2021)
128. Thondala B, "The effect of non-pharmacological interventions on sleep quality in people with sleep disturbances : A systematic review and a meta-analysis", Chronobiol Int, 40, pp.1333~1353 (2023)
129. Addison AB, "Clinical olfactory working group consensus statement on the treatment of postinfectious olfactory dysfunction", J Allergy Clin Immunol, 147, pp.1704~1719 (2021)
130. Asvapoositkul V, "Therapeutic options of post-COVID-19 related olfactory dysfunction : a systematic review and meta-analysis", Rhinology, 61, pp.2~11 (2023)
131. Vaira LA, "Efficacy of corticosteroid therapy in the treatment of long-lasting olfactory disorders in COVID-19 patients", Rhinology, 59, pp.21~25 (2021)
132. Hosseinpoor M, "Intranasal corticosteroid treatment on recovery of long-term olfactory dysfunction due to COVID-19", Laryngoscope, 132, pp.2209~2216 (2022)
133. Wormgoor MEA, "Focus on post-exertional malaise when approaching ME", CFS in specialist healthcare improves satisfaction and reduces deterioration, 2023, pp.14, 1247698~
134. Sanal-Hayes NEA, "A scoping review of ‘Pacing’ for management of Myalgic Encephalomyelitis", Chronic Fatigue Syndrome(ME, J Transl Med, pp.2023, 21[DOI]
135. "Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)"[URL]
136. Amekran Y, "Postural orthostatic tachycardia syndrome and post-acute COVID-19", Glob Cardiol Sci Pract, 2022, pp.e202213~ (2022)
137. Baptista AF, "Applications of non-invasive neuromodulation for the management of disorders related to COVID-19", Front Neurol, 11, pp.573718~ (2020)
138. Desai AD, "Management of arrhythmias associated with COVID-19", Curr Cardiol Rep, 23, pp.2~ (2020)
139. Ramacciotti E, "Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19(MICHELLE) : an open-label, multicentre, randomised, controlled trial", Lancet, 399, pp.50~59 (2022)
140. Wang TY, "Effect of thromboprophylaxis on clinical outcomes after COVID-19 hospitalization", Ann Intern Med, 176, pp.515~523 (2023)
141. Ortel TL, "American Society of Hematology 2020 guidelines for management of venous thromboembolism : treatment of deep vein thrombosis and pulmonary embolism", Blood Adv, 4, pp.4693~4738 (2020)
142. National Institutes of Health (NIH), "COVID-19 treatment guidelines: coronavirus disease 2019 (COVID-19) treatment guidelines", NIH, ~ (2021)
143. Singh P, "Nintedanib vs pirfenidone in the management of COVID-19 lung fibrosis : a single-centre study", J R Coll Physicians Edinb, 52, pp.100~104 (2022)
144. Choudhary R, "Effectiveness and safety of pirfenidone and nintedanib for pulmonary fibrosis in COVID-19-induced severe pneumonia : an interventional study", Cureus, 14, pp.e29435~ (2022)
145. Kerget B, "When and how important is anti-fibrotic therapy in the post-COVID-19 period?", Bratisl Lek Listy, 123, pp.653~658 (2022)
146. Choi YJ, "Effectiveness of antiviral therapy on long COVID : a systematic review and meta-analysis", J Clin Med, 12, pp.7375~ (2023)
147. Chilunga FP, "Differences in incidence, nature of symptoms, and duration of long COVID among hospitalised migrant and non-migrant patients in the Netherlands : a retrospective cohort study", Lancet Reg Health Eur, 29, pp.100630~ (2023)
148. Xie Y, "Molnupiravir and risk of post-acute sequelae of covid-19 : cohort study", BMJ, 381, pp.e074572~ (2023)
149. Park HR, "Effectiveness of molnupiravir treatment in patients with COVID-19 in Korea : a propensity score matched study", Infect Chemother, 55, pp.490~499 (2023)
150. Ceban F, "COVID-19 vaccination for the prevention and treatment of long COVID : a systematic review and meta-analysis", Brain Behav Immun, 111, pp.211~229 (2023)
151. Watanabe A, "Protective effect of COVID-19 vaccination against long COVID syndrome : a systematic review and meta-analysis", Vaccine, 41, pp.1783~1790 (2023)
152. Choi S, "Severity of COVID-19 pneumonia in kidney transplant recipients according to SARS-CoV-2 vaccination", Infect Chemother, 55, pp.505~509 (2023)
153. Choi WS, "Adult immunization policy in Korea", Infect Chemother, 55, pp.317~321 (2023)

관련 논문AI추천